by Glenn S. Demby | Feb 24, 2022 | Articles , News , Open Content
False ordering and billing of cancer genetic (CGx) tests has become a favorite target for federal fraud enforcers, with the U.S. Department of Justice (DOJ) reporting two notable convictions in the closing months of 2021. On Nov. 17, a 57-year-old former lab sales rep...
by Glenn S. Demby | Feb 18, 2022 | Articles , Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Emerging Tests-dtet
Research team creates a promising new mass spectrometry-based blood lipid test.
This content is for Paid Members only.
Register
by Glenn S. Demby | Jan 19, 2022 | Articles , Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Emerging Tests-dtet
...
This content is for Paid Members only.
Register
by Glenn S. Demby | Jan 5, 2022 | Articles , Dx Pipeline-lir , Essential , Laboratory Industry Report
...
This content is for Paid Members only.
Register
by Glenn S. Demby | Oct 5, 2021 | Articles , Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Testing Trends-dtet
...
This content is for Paid Members only.
Register